De Smet Tom, Struys Michel M R F, Neckebroek Martine M, Van den Hauwe Kristof, Bonte Sjoert, Mortier Eric P
Demed Engineering, Temse, Belgium.
Anesth Analg. 2008 Oct;107(4):1200-10. doi: 10.1213/ane.0b013e31817bd1a6.
Closed-loop control of the hypnotic component of anesthesia has been proposed in an attempt to optimize drug delivery. Here, we introduce a newly developed Bayesian-based, patient-individualized, model-based, adaptive control method for bispectral index (BIS) guided propofol infusion into clinical practice and compare its accuracy and clinical feasibility under direct observation of an anesthesiologist versus BIS guided, effect compartment controlled propofol administration titrated by the anesthesiologist during ambulatory gynecological procedures.
Forty ASA patients were randomly allocated to the closed-loop or manual control group. All patients received midazolam 1 mg IV and alfentanil 0.5 mg IV before induction. In the closed-loop control group, propofol was administered using the previously described closed-loop control system to reach and maintain a target BIS of 50. In the manual control group, the propofol effect-site concentration was adapted at the discretion of the anesthesiologist to reach and maintain a BIS as close as possible to 50. Induction characteristics, performance, and robustness during maintenance and recovery times were compared. Hemodynamic and respiratory stability were calculated as clinical feasibility parameters.
The closed-loop control system titrated propofol administration accurately resulting in BIS values close to the set point. The closed-loop control system was able to induce the patients within clinically accepted time limits and with less overshoot than the manual control group. Automated control resulted in beneficial recovery times. Our closed-loop control group showed similar acceptable clinical performance specified by similar hemodynamic, respiratory stability, comparable movement rates, and quality scores than the manual control group.
The Bayesian-based closed-loop control system for propofol administration using the BIS as a controlled variable performed accurate during anesthesia for ambulatory gynecological procedures. This control system is clinical feasibility and can be further validated in clinical practice.
为优化药物输注,有人提出对麻醉催眠成分进行闭环控制。在此,我们将一种新开发的基于贝叶斯、患者个体化、基于模型的自适应控制方法引入临床实践,该方法用于在双谱指数(BIS)引导下输注丙泊酚,并在门诊妇科手术中,比较其在麻醉医生直接观察下与麻醉医生根据BIS引导、效应室控制丙泊酚给药滴定法的准确性和临床可行性。
40例美国麻醉医师协会(ASA)分级的患者被随机分配至闭环或手动控制组。所有患者在诱导前静脉注射咪达唑仑1mg和阿芬太尼0.5mg。在闭环控制组,使用先前描述的闭环控制系统输注丙泊酚,以达到并维持目标BIS值为50。在手动控制组,丙泊酚效应室浓度由麻醉医生酌情调整,以达到并维持BIS值尽可能接近50。比较诱导特征、维持和恢复期间的性能及稳健性。计算血流动力学和呼吸稳定性作为临床可行性参数。
闭环控制系统能准确滴定丙泊酚给药,使BIS值接近设定点。与手动控制组相比,闭环控制系统能在临床可接受的时间范围内诱导患者,且超调量更小。自动控制使恢复时间缩短。我们的闭环控制组在血流动力学、呼吸稳定性、可比的运动发生率和质量评分等方面表现出与手动控制组相似的可接受的临床性能。
以BIS作为控制变量的基于贝叶斯的丙泊酚给药闭环控制系统在门诊妇科手术麻醉期间表现准确。该控制系统具有临床可行性,可在临床实践中进一步验证。